Mark Gurney — Insider Trading History & SEC Filings
SEC CIK 1258051 — Sr. VP Drug Discovery & Dvpmt
Mark Gurney is a corporate insider tracked via SEC EDGAR filings. Officers, directors, and 10%+ beneficial owners must report transactions in their company's stock on Form 4, typically within two business days. This page shows Mark Gurney's reported transactions, current holdings across companies, and filing history.
Frequently asked questions
Who is Mark Gurney?
Mark Gurney is a corporate insider (SEC CIK 1258051) with reported roles including Sr. VP Drug Discovery & Dvpmt. This page tracks their SEC Form 4, Form 3, and Form 5 filings, current holdings, and transaction history.
How current is this insider data?
Insiders must report transactions to the SEC typically within two business days. finshort ingests new EDGAR filings continuously, so transactions appear shortly after they are filed.